Regeneron Pharmaceuticals, Inc.
May 18, 2017

Regeneron Announces Upcoming Investor Conference Presentations

TARRYTOWN, N.Y., May 18, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations as follows:

  • Bernstein 33rd Annual Strategic Decisions Conference at 5:00 p.m. ET on Wednesday, May 31, 2017
  • Goldman Sachs 38th Annual Global Healthcare Conference at 8:40 a.m. PT (11:40 a.m. Eastern Time) on Tuesday, June 13, 2017

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:                       

Investor Relations

Corporate Communications


Manisha Narasimhan, Ph.D.

Hala Mirza


914.847.5126

914.847.3422


manisha.narasimhan@regeneron.com

hala.mirza@regeneron.com


 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300459452.html

SOURCE Regeneron Pharmaceuticals, Inc.

News Provided by Acquire Media